Table 5.
Age group, years | High risk (n = 846), n (%) |
Intermediate risk (n = 2,423), n (%) |
||
---|---|---|---|---|
chemotherapy | no chemotherapy | chemotherapy | no chemotherapy | |
<20 | 0 | 0 | 0 | 0 |
20–29 | 5 (83.3) | 1 (16.7) | 5 (55.6) | 4 (44.4) |
30–39 | 37 (74.0) | 13 (26.0) | 59 (61.5) | 37 (38.5) |
40–49 | 121 (80.1) | 30 (19.9) | 237 (63.9) | 134 (36.1) |
50–59 | 144 (77.4) | 42 (22.6) | 341 (63.3) | 198 (36.7) |
60–69 | 161 (70.9) | 66 (29.1) | 380 (49.2) | 393 (50.8) |
70–79 | 87 (51.8) | 81 (48.2) | 86 (20.2) | 340 (79.8) |
80–89 | 2 (3.5) | 55 (96.5) | 6 (3.1) | 189 (96.9) |
90–99 | 0 | 1 (100) | 0 | 13 (100) |
Total | 557 (65.8%) | 289 (34.2%) | 1,11 5 (46.0%) | 1,308 (54.0%) |